Results 151 to 160 of about 2,340,109 (293)

Advancing Systemic Risk Assessment for Complex, Interdependent Systems: A Research Agenda. [PDF]

Risk Anal
Logan T, Rachunok B, Hardaway K, Bristow D, Reilly A, Johnson D, Johansson J, Cremen G, Boakye J, Schweizer P.   +9 more
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Systemic risk mitigation in supply chains through network rewiring. [PDF]

Sci Rep
Zelbi G, Ialongo LN, Thurner S.
europepmc   +1 more source

Systemic risk prevention policies targeting systemically important banks: Does clustering pattern matter? [PDF]

PLoS One, 2023
Zhu B, Hu X, Deng Y, Lin R.
europepmc   +1 more source

The threat of systemic risk in banking: Evidence for Europe [PDF]

This paper attempts to answer the question whether the threat of systemic risk in banking exists only on a national or on a European level. Following De Nicolo and Kwast (2001), mean rolling-window correlations between bank stock returns are used as a ...
Schüler, Martin
core  

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

Arthritis Care &Research, EarlyView.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel   +19 more
wiley   +1 more source

Rethinking flood resilience: systemic risk, governance failures, and the social production of vulnerability in the Himalayan-Indus region. [PDF]

J Disaster Sci Manag (Singap)
Hamidi AR, Ford JD, Novo P, Paavola J, Malik IH.   +4 more
europepmc   +1 more source

Dynamic Banking Systemic Risk Accumulation under Multiple-Risk Exposures. [PDF]

Entropy (Basel), 2022
Fan H, Tang M.
europepmc   +1 more source

Systemic risk and the financial crisis: a primer [PDF]

How did problems in a relatively small portion of the home mortgage market trigger the most severe financial crisis in the United States since the Great Depression?
Christopher J. Neely, David C. Wheelock, James B. Bullard   +2 more
core  

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

Arthritis Care &Research, EarlyView.
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte‐García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore‐Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son   +20 more
wiley   +1 more source